Beneficial effects of Akkermansia muciniphila on benign prostatic hyperplasia and metabolic syndrome
Authors:
- 9 January 2025
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 768, 110294
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modificationsCancer Letters, 2021
- Effects of continuous intravenous infusion of propofol on intestinal flora in ratsBiomedicine & Pharmacotherapy, 2021
- A potential therapeutic strategy for prostatic disease by targeting the oral microbiomeMedicinal Research Reviews, 2020
- Escherichia coli, a common constituent of benign prostate hyperplasia‐associated microbiota induces inflammation and DNA damage in prostate epithelial cellsThe Prostate, 2020
- Further analysis reveals new gut microbiome markers of type 2 diabetes mellitusAntonie van Leeuwenhoek, 2016
- Metabolic endotoxemia with obesity: Is it real and is it relevant?Biochimie, 2016
- Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients With Psoriatic Arthritis, Resembling Dysbiosis in Inflammatory Bowel DiseaseArthritis & Rheumatology, 2014
- Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4Immunity, 2014
- The Correlation Between Metabolic Syndrome and Prostatic DiseasesEuropean Urology, 2012
- EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines)European Urology, 2004